(Q24250116)

English

Olanzapine in long-term treatment for bipolar disorder

scientific article (published 2003-04-22)

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

0 references

title

Olanzapine in long-term treatment for bipolar disorder (English)

0 references

1 reference

A Cipriani

1

0 references

J Rendell

series ordinal

2

0 references

J Geddes

series ordinal

3

0 references

publication date

22 April 2003

0 references

published in

Cochrane Database of Systematic Reviews

0 references

cites work

Health care utilization and costs among patients treated for bipolar disorder in an insured population.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

21 January 2018

Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar Disorder

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

21 January 2018

A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Risperidone alone or in combination for acute mania

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Historical perspectives and natural history of bipolar disorder

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacologic agents for the treatment of acute bipolar mania.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality of patients with mood disorders: follow-up over 34-38 years

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of tardive dyskinesia in a bipolar patient with olanzapine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Manic symptoms induced by olanzapine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of DSM-III-R bipolar I disorder in a general population survey.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Are patients with bipolar affective disorder socially disadvantaged? A comparison with a control group.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Can olanzapine be implicated in causing serotonin syndrome?

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine usage associated with neuroleptic malignant syndrome.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Suicide as an outcome for mental disorders. A meta-analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine-lnduced hyperglycemic nonketonic coma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Olanzapine-induced glucose dysregulation.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonadherence with mood stabilizers: prevalence and predictors

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2F14651858.CD004367

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1002/14651858.CD004367

0 references

(Q24250116)

Olanzapine in long-term treatment for bipolar disorder

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)